Document Detail

Midterm to long-term longitudinal outcome of autologous chondrocyte implantation in the knee joint: a multilevel analysis.
MedLine Citation:
PMID:  19861698     Owner:  NLM     Status:  In-Process    
BACKGROUND: Autologous chondrocyte implantation is a cell therapeutic approach for the treatment of chondral and osteochondral defects in the knee joint. The authors previously reported on the histologic and radiologic outcome of autologous chondrocyte implantation in the short- to midterm, which yields mixed results. PURPOSE: The objective is to report on the clinical outcome of autologous chondrocyte implantation for the knee in the midterm to long term. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Eighty patients who had undergone autologous chondrocyte implantation of the knee with mid- to long-term follow-up were analyzed. The mean patient age was 34.6 years (standard deviation, 9.1 years), with 63 men and 17 women. Seventy-one patients presented with a focal chondral defect, with a median defect area of 4.1 cm(2) and a maximum defect area of 20 cm(2). The modified Lysholm score was used as a self-reporting clinical outcome measure to determine the following: (1) What is the typical pattern over time of clinical outcome after autologous chondrocyte implantation; and (2) Which patient-related predictors for the clinical outcome pattern can be used to improve patient selection for autologous chondrocyte implantation? RESULTS: The average follow-up time was 5 years (range, 2.7-9.3). Improvement in clinical outcome was found in 65 patients (81%), while 15 patients (19%) showed a decline in outcome. The median preoperative Lysholm score of 54 increased to a median of 78 points. The most rapid improvement in Lysholm score was over the 15-month period after operation, after which the Lysholm score remained constant for up to 9 years. The authors were unable to identify any patient-specific factors (ie, age, gender, defect size, defect location, number of previous operations, preoperative Lysholm score) that could predict the change in clinical outcome in the first 15 months. CONCLUSION: Autologous chondrocyte implantation seems to provide a durable clinical outcome in those patients demonstrating success at 15 months after operation. Comparisons between other outcome measures of autologous chondrocyte implantation should be focused on the clinical status at 15 months after surgery. The patient-reported clinical outcome at 15 months is a major predictor of the mid- to long-term success of autologous chondrocyte implantation.
Abhijit M Bhosale; Jan Herman Kuiper; W Eustace B Johnson; Paul E Harrison; James B Richardson
Related Documents :
24956468 - In-situ implant containing pcl-curcumin nanoparticles developed using design of experim...
24484518 - Continuing professional development in implant dentistry in europe.
23014078 - Permeability and smear layer removal: effects of different chemical agents on the prima...
19181978 - Treatment of osteonecrosis of the humeral head with cementless surface replacement arth...
10687538 - Evaluation of microbial infiltration in restored cavities--an alternative method.
24021588 - Effect of microthread design of dental implants on stress and strain patterns: a three-...
Publication Detail:
Type:  Journal Article     Date:  2009-10-27
Journal Detail:
Title:  The American journal of sports medicine     Volume:  37 Suppl 1     ISSN:  1552-3365     ISO Abbreviation:  Am J Sports Med     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7609541     Medline TA:  Am J Sports Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  131S-8S     Citation Subset:  IM    
Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Oswestry, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for oste...
Next Document:  Recommendations and Treatment Outcomes for Patellofemoral Articular Cartilage Defects With Autologou...